INTRODUCTION
Psoriasis, a common chronic inflammatory skin disease, is characterized by abnormal proliferation and differentiation of keratinocytes. Further, an abnormality in the Th17 pathway is the immunologic contributor to keratinocyte proliferation 1 . Recent reports [2] [3] [4] have described the upregulation of Wnt5a in psoriasis, but the underlying mechanisms have not been elucidated. In this context, previous studies have reported negative regulation of Wnt canonical signaling, and suggested Notch1 to be a tumor suppressor in mouse skin 5, 6 .
Wnt5a is the prototypical non-canonical Wnt family ligand. Apart from its complex role in development, Wnt5a, which is expressed in a variety of adult tissues, promotes cell proliferation [7] [8] [9] as well as adhesion of fibroblasts 10, 11 .
Recent evidences support the involvement of Wnt5a in inflammatory responses and innate immunity 12, 13 . Meanwhile, the Notch system plays a crucial role in epidermal cell growth and differentiation 14, 15 . It consists of four transmembrane receptors (Notch1∼4), five transmembrane ligands (Jagged-1 and -2; and Delta-like-1, -3, and -4), and three regulatory proteins (lunatic, radical, and manic fringe) that modulate ligand-receptor-induced signals 16 .
Previous studies have suggested the possible involvement of Notch1 in psoriasis 17, 18 .
Wnt and Notch signaling are involved in several pathways depending on the cell line and disease. However, the interaction between the Wnt5a and Notch1 in psoriasis has not yet been studied. Moreover, although aberrant differentiation and uncontrolled proliferation is a key feature of the psoriatic epidermis, the role of these processes and their possible association with immune cells are obscure. Therefore, in this study, we investigated the interaction between Wnt5a and Notch1 signaling in the pathogenesis of psoriasis.
MATERIALS AND METHODS

Study subjects
Ten patients with psoriasis were recruited for the study. All donors provided written informed consent, and all procedures were conducted upon approval by the ethics committee of Asan Medical Center (No. 2004-0161).
Quantitative reverse transcription-polymerase chain reaction analyses of psoriatic lesional and non-lesional skin samples
Two punch biopsies (3∼5 mm diameter) were obtained from lesional and non-lesional skin samples of each patient. Total RNA from the biopsy tissues was isolated using an RNeasy isolation kit (Qiagen, Hilden, Germany). cDNA was synthesized using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed using SYBR green PCR reagents (Roche Applied Science, Indianapolis, IN, USA). GAPDH was used as endogenous reference gene, and all experiments were performed thrice. The following specific primers were used: Wnt5a, 5'-TAG CAG CAT CAG TCC ACA AA-3' (sense) and 5'-CAA AAC ACG GCA TCT CTC TT-3' (antisense); Notch1, 5'-TGC GAG GTC AAC ACA GAC GAG-3' (sense) and 5' TGT AAG TGT TGG GTC CGT CCA G-3' (antisense); HES1, 5'-ATG GAG AAA AAT TCC TCG TCC C-3' (sense) and 5'-TTC AGA GCA TCC AAA ATC AGT GT-3' (antisense); and GAPDH, 5'-ATG GGG AAG GTG AAG GTC G-3' (sense) and 5'-GGG GTC ATT GAT GGC AAC AAT A-3' (antisense).
Immunohistochemistry
Acetone-fixed cryostat sections and formalin-fixed paraffin-embedded sections were immunostained using an Elite ABC Kit (Vector Laboratories, Burlingame, CA, USA). The primary antibodies used in this study are listed in Table 1 .
Positively stained cells were scored as follows: 0, no activity; 1, ≤10%; 2, 10% to ≤25%; 3, 25% to ≤50%; 4, 50% to ≤75%; 5, ＞75%. /well) were incubated in a 96-well microtiter plate with culture medium at a final volume of 100 μl/well. Next day, the cells were treated with rWnt5a (100 ng/ml) and transfected with Wnt5a-specific and negative control siRNAs (3 pmol; Bioneer, Daejeon, Korea) using Lipofectamine RNAiMAX transfection reagent (Invitrogen). Cell proliferation was determined after 2 and 3 d using Cell Proliferation enzyme-linked immunosorbent assay (ELISA), Bromodeoxyuridine (BrdU) (Roche Applied Science) following the manufacturer's instructions.
Migration assay
The migration of HDFs and NHKs were assayed using Boyden chambers with 8 μm pore membranes (Transwell; Coster, Boston, MA, USA). Lower surfaces of the transwell membranes were coated with gelatin B (10 μg/ml), following which the membranes were allowed to dry at 25 o C for 1 h. The transwells were assembled in a 24-well plate, and the lower chambers were filled with either control-or Wnt5a-conditioned media containing 100 ng/ml basic-fibroblast growth factor. Cells were cultured in either control-or Wnt5a-conditioned media for 3 d, following which 5×10 4 cells were added to the upper chambers.
The plate was then incubated at 37 o C for 24 h. The cells that migrated to the lower surface of the filters were stained, and enumerated in four randomly selected fields.
Western blotting Total proteins (30 μg) were resolved by SDS PAGE and probed with anti-phospho-AKT (Ser473) (Cell Signaling, 1:500) and -AKT antibodies (Cell Signaling, 1:500). Densitometric analyses were performed using a VersaDoc Imaging System (Bio-Rad, Hercules, CA, USA).
Enzyme-linked immunosorbent assay
Cytokines secreted by the Wnt5a-treated NHKs were detected using specific ELISAs. Cells were treated with rWnt5a (100 ng/ml) for 6, 24, 48, and 72 h. The culture media were harvested and ELISAs for TNF-α (Invitrogen) and IL-1α (R&D Systems) were performed according to the manufacturer's instructions. Optical densities were measured using a microplate reader (Molecular Devices, Sunnyvale, CA, USA).
Reverse transcription-polymerase chain reaction for rWnt5a-treated cells staining, ×400) showed that protein levels of Notch1 (upper panel) were decreased in all the layers of psoriatic lesions (left) compared with non-lesional skin samples (right). HES1 (lower panel) was also decreased at the protein level in psoriatic lesional samples. 
RESULTS
Wnt5a is increased in psoriatic lesions
qRT-PCR analyses showed that Wnt5a mRNA levels increased about 2.4-fold (p＜0.001) in the psoriatic lesions compared with that in non-lesional skin samples (Fig. 1A) . These results were confirmed by immunohistochemistry (IHC), which showed increased Wnt5a staining in all the layers of lesional skin compared with that in non-lesional skin samples (Fig. 1B, Table 2 ).
HES1 is decreased in lesional psoriatic skin
The mRNA levels of several Notch signaling components were evaluated by RT-PCR. There was no change in NOTCH1 mRNA expression in the psoriatic skin biopsies, while that of HES1 was decreased (Fig. 2) . IHC analyses confirmed the decrease in Notch1 and HES1 expression at their protein levels in psoriatic lesions compared with that in non-lesional skin samples. Notch1 was distributed from spinous to granular layers of the normal epidermis, but was markedly decreased in psoriatic lesions. IHC staining scores for Notch2, Delta-like 1, and Jagged-1 were also decreased in the psoriatic skin samples, whereas Jagged-2 expression remained unaltered (Table 2 ).
Wnt5a induces proliferation of keratinocytes
Treatment with rWnt5a stimulated the proliferation of cultured NHKs, as demonstrated by BrdU-incorporation assays. The percentage of BrdU-positive NHKs increased to 110.1% and 126.0% after treatment with rWnt5a for 2 and 3 d, respectively (Fig. 3A) . The number of cells decreased to 82.8% and 43.0%, respectively, 2 and 3 d after transfection with siRNAs against Wnt5a (Fig. 3B ).
Wnt5a expression in keratinocytes induces fibroblast but not keratinocyte migration Treatment of NHKs with Wnt5a did not induce keratinocyte migration, as assessed using Boyden chamber assays. (1) Untreated NHKs (control), (2) IL-1α (10 ng/ml), (3) TNF-α (10 ng/ml), (4) TGF-α (24 ng/ml), (5) IFN-γ (20 ng/ml), (6) cytokine mixture of IL-1α (10 ng/ml), and TNF-α (10 ng/ml), (7) IL-1α (10 ng/ml), TNF-α (10 ng/ml), TGF-α (24 ng/ml), and IFN-γ (20 ng/ml)-treated NHKs. (B) Analysis of rWnt5a-treated NHK culture media by enzyme-linked immunosorbent assay (ELISA). Cells were treated with rWnt5a (100 ng/ml) for 6, 24, 48, and 72 h, following which the culture media were harvested. TNF-α and IL-1α production (pg/ml) were determined by ELISA. Data represent the mean±standard deviation. *p-value＜0.05, **p-value＜0.01; determined by the Student's t-test. (C) NHKs were treated with rWnt5a (100 ng/ml) for 1, 3, 6, 24, and 72 h, following which the expression levels of NOTCH1 and HES1 were determined by reverse transcription polymerase chain reaction.
However, treatment of HDFs with conditioned media from Wnt5a-treated NHKs induced a 1.4-fold increase in the migration of HDFs (Fig. 4) .
Counteracting expression of Wnt5a and Notch1 in the milieu of proinflammatory cytokines
To model the effects of a proinflammatory cytokine environment on Wnt5a expression in keratinocytes, we stimulated NHKs with TNF-α, IFN-γ, TGF-α, and IL-1α for 24 h. This decreased the Notch1 and HES1 protein levels while increasing that of Wnt5a (Fig. 5A) . Moreover, ELISAs demonstrated that treatment of NHKs with rWnt5a increased the levels of TNF-α and IL-1α in the supernatant compared with that in controls (Fig. 5B ). Notch1 and HES1 were downregulated in rWnt5a-treated NHKs, as demonstrated by RT-PCR (Fig. 5C ).
Intracellular signaling is activated in Wnt5a-treated keratinocytes
Silver staining and western blotting with anti-phosphorylated-AKT (p-AKT) antibody revealed the presence of a 50 kDa tyrosine-phosphorylated protein (consistent with the molecular weight of AKT) in NHKs infected with Wnt5a adenovirus (data not shown). This suggested that intracellular AKT signaling was substantially activated in the Wnt5a-overexpressing cells. To rule out possible signaling effects due to adenoviral infection alone, we tested the effects of exogenously applied rWnt5a. Similar to the results obtained with adenoviral-mediated Wnt5a infection, western blot analyses showed an increase in p-AKT in the rWnt5a-treated cells (Fig. 6 ). 
DISCUSSION
Psoriasis is a chronic inflammatory disease accompanied by hyperproliferation of keratinocytes. Although the uncontrolled proliferation of keratinocytes has been much emphasized upon, deregulated differentiation is also an important aspect of psoriatic keratinocytes 1 . Proteins associated with early differentiation, including involucrin, are highly expressed in the early layers, whereas the expression of late-differentiation markers, including loricrin and filaggrin, are markedly diminished in psoriasis 19 .
Psoriasis, therefore, involves immune-deregulated keratinocytes.
In the skin, the fate of keratinocytes-proliferation versus differentiation-is determined by the action of Notch versus p63 15, 20 . Notch signaling is a "direct" determinant of keratinocyte growth arrest and entry into terminal differentiation in NHKs and skin 21 . Thus, the Notch signaling pathway is important for cell-cell communication, and is involved in gene regulatory mechanisms that control a number of cellular processes, including cell fate decisions, stem cell maintenance, proliferation, differentiation, and survival. Notch reporters undergo successive cleavages, leading to the release of their activated form, the Notch intracellular domain (NID). The NID translocates to the nucleus and forms a complex with DNA-binding proteins, thereby activating transcription 22, 23 . This interaction results in the expression of various target genes, including HES and HES-related repressor protein (HEY) 24 . A major downstream effector of Notch1 in human keratinocytes and fibroblasts is HES1 25, 26 . Notch activation also upregulates early-differentiation markers such as keratin1 and involucrin 21 .
In normal skin, Notch1 is distributed in all the layers, while Notch2 is present only in the basal layer, though their ligands exhibit similar distribution patterns 25, 27 . Here, we found that Notch1 protein levels were decreased in lesional skin samples, together with decrease in both HES1 mRNA and protein. It is notable that we did not separate the epidermis and dermis of the psoriatic lesion. Therefore, dermal components including fibroblasts and vascular structures, might have countervailed the decrease in epidermal NOTCH1 mRNA in lesional skin 28, 29 . Immunohistochemical analyses further showed that expression of the Notch1 ligand, Delta-like-1, was also decreased in lesional psoriatic epidermis compared with that in both non-lesional and normal skin samples. Downregulation of Notch1 and HES1 in psoriatic epidermis suggests defective Notch1 signaling in psoriasis, which is likely attributable to deregulation of the normal keratinocyte differentiation process. treatment enhanced the migration of HDFs and enhanced the proliferation of both NHKs and HDFs. Unfortunately, it was not possible to study the effects of Wnt5a signal directly in these native cells, which were scant in the psoriatic dermis. However, we did find another evidence for the effect of Wnt5a signaling on cellular behavior and interaction. Importantly, treatment of NHKs with TNF-α, IL-1α, IFN-γ, or TGF-α increased Wnt5a and decreased Notch1 and HES1 levels. Treatment with rWnt5a substantially decreased Notch1 and HES1 and increased TNF-α and IL-1 levels. This corroborates the idea that Wnt5a is an important link between immunologic alterations and deregulation of psoriatic keratinocytes in the pathomechansim of the disease. The current data thus suggest that Wnt5a is responsible for abnormal proliferation and differentiation of keratinocytes as well as epidermal inflammation through negative regulation of Notch1 signaling. It is, therefore, an important player in the pathophysiology of psoriasis. A recent study reported that transgenic mice overexpressing epidermal Wnt5a possessed normal, not psoriatic hyperproliferative epidermis 37 . Therefore, it is still unclear whether increased Wnt5a in psoriatic lesions is the causal pathomechanism or simply an attempt by the organism to restore normal skin phenotype 2 . Based on our results, we propose that Wnt5a participates in two pathomechanisms of psoriasis. The first relates to similarities between events associated with psoriatic keratinocytes and wound healing. Wnt5a is mostly involved in fibroblast activation, and we previously reported an association between Wnt5a upregulation and wound healing of laser-treated skin 38 . Proliferation and aberrant differentiation of psoriatic keratinocytes might involve modification of Wnt5a signaling in the psoriatic epidermis. In our study, the psoriatic epidermis showed increased and decreased expression of Wnt5a and Notch1, respectively. rWnt5a also stimulated the proliferation of NHKs in our study, and increased the levels of activated AKT. The second possible pathomechanism involves the link between increased Wnt5a in psoriatic epidermis and inflammation. A recent study showed that genetic expression of Wnt5a did not return to the baseline after restoring psoriatic epidermis to normal-appearing skin. Although epidermal inflammation was relieved by ＞75% in treated psoriatic patients, dermal CD8+ cells were not fully resolved. These findings suggest that Wnt5a is associated with a network of cytokines and inflammatory responses in psoriasis 39 .
In conclusion, Wnt5a/Notch signaling serves a counterbalancing function in the pathomechanism of psoriasis. This study highlights the potential therapeutic application of Notch-enhancing and/or Wnt5a-inhibitory peptides in psoriasis. Further studies are warranted, including investigation of a wide range of cytokines affected by Wnt5a/Notch signaling and large-scale genetic studies of patient skin biopsy samples. 
